Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid Royal Caribbean Cruises Ltd. (RCL)?

Page 1 of 2

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors endured a torrid quarter, which certainly propelled them to adjust their equity holdings so as to maintain the desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards Royal Caribbean Cruises Ltd. (NYSE:RCL).

Is Royal Caribbean Cruises Ltd. (NYSE:RCL) a good investment? The smart money is in a slightly pessimistic mood. The number of long hedge fund bets retreated by 2 lately. RCL was in 41 hedge funds’ portfolios at the end of September. There were 43 hedge funds in our database with RCL positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Consolidated Edison, Inc. (NYSE:ED), Ameriprise Financial, Inc. (NYSE:AMP), and Cummins Inc. (NYSE:CMI) to gather more data points.

Follow Royal Caribbean Cruises Ltd (NYSE:RCL)
Trade (NYSE:RCL) Now!

In the eyes of most investors, hedge funds are perceived as slow, outdated financial tools of years past. While there are greater than 8000 funds with their doors open today, We hone in on the leaders of this group, about 700 funds. It is estimated that this group of investors oversee bulk of the smart money’s total asset base, and by following their unrivaled investments, Insider Monkey has spotted numerous investment strategies that have historically beaten the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy outperformed the S&P 500 index by 12 percentage points annually for a decade in their back tests.

With all of this in mind, let’s go over the fresh action surrounding Royal Caribbean Cruises Ltd. (NYSE:RCL).

What have hedge funds been doing with Royal Caribbean Cruises Ltd. (NYSE:RCL)?

Heading into Q4, a total of 41 of the hedge funds tracked by Insider Monkey were long this stock, a change of -5% from the second quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were increasing their holdings considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Columbus Circle Investors, managed by Clifford Fox, holds the largest position in Royal Caribbean Cruises Ltd. (NYSE:RCL). Columbus Circle Investors has a $187.1 million position in the stock, comprising 1.5% of its 13F portfolio. The second largest stake is held by Altimeter Capital Management, led by Brad Gerstner, holding a $110.6 million position; the fund has 7.1% of its 13F portfolio invested in the stock. Some other members of the smart money that hold long positions include Cliff Asness’s AQR Capital Management, Brett Barakett’s Tremblant Capital and Ken Griffin’s Citadel Investment Group.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!